DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Saphris (Asenapine Maleate) - Current Clinical Trials

 
 



Saphris Related Clinical Trials

Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896) [Completed]

Once-Daily Asenapine for Schizophrenia [Completed]

Bio-equivalence Study Between SAPHRIS and Asenapine [Completed]

Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691) [Completed]

Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107) [Completed]

Long-Term Safety Extension Trial of Asenapine in Bipolar 1 Disorder Participants Who Completed Protocol P05691 (P05692) [Completed]

Study of Asenapine in Elderly Subjects With Psychosis (A7501021)(P05717) [Completed]

An Open Label Pilot Study of Adjunctive Asenapine for the Treatment of Posttraumatic Stress Disorder [Recruiting]

Asenapine in the Treatment of Older Adults With Bipolar Disorder [Completed]

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384) [Completed]

To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770) [Completed]

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1) [Completed]

Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression [Active, not recruiting]

Asenapine for Bipolar Depression [Recruiting]

Long-Term Safety Extension Trial of Asenapine in Schizophrenia Participants Who Completed Protocol P05688 (P05689) [Completed]

Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897) [Completed]

An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED) [Completed]

Investigator Initiated Study - Asenapine Early Psychosis [Not yet recruiting]

A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering [Suspended]

Treating Acutely Agitated Patients With Asenapine Sublingual Tablets [Completed]

Long-term Extension Trial of Asenapine in Subjects With Schizophrenia (Study P06125) [Completed]

An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308) [Active, not recruiting]

6-week Trial of the Efficacy and Safety of Asenapine Compared to Placebo in Participants With an Acute Exacerbation of Schizophrenia (P06124) [Completed]

Extension Study of Asenapine [P06107 (NCT01244815)] for Pediatric Bipolar Disorder (P05898) [Completed]

Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785) [Completed]

9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED) [Completed]

40 Week Extension Study Of Asenapine and Olanzapine For Bipolar Disorder (A7501007)(COMPLETED)(P05857) [Completed]

40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(P05786) [Completed]

A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688) [Completed]

12 Week Study of the Safety/Efficacy of Asenapine When Added to Lithium/Valproate in the Treatment of Bipolar Disorder (A7501008)(COMPLETED)(P05844) [Completed]

Bioequivalence Fasting Study in Patients [Completed]

Long-Term Efficacy and Safety of Asenapine Using Olanzapine as a Positive Control (41512)(COMPLETED)(P05784) [Completed]

Efficacy and Safety of Asenapine With Placebo and Olanzapine (41022)(P05947) [Completed]

A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 (Asenapine) Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937) [Completed]

Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(COMPLETED) [Completed]

3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008) [Completed]

3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (A7501005)(COMPLETED) [Completed]

Long-term Study of Asenapine in Subjects With Residual Subtype, Receiving Multiple or/and High Dose Drugs, or Treatment Refractory Schizophrenia (P06238) [Completed]

Efficacy and Safety of Asenapine With Placebo and Olanzapine (41021)(P05933) [Completed]

Observational Post-Authorisation Safety Study of Asenapine (Sycrest) [Recruiting]

An Observational Modified Prescription-event Monitoring Study of Asenapine (Sycrest) [Recruiting]

6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptoms Patients Who Completed the First 6- Month Trial (A7501014)(COMPLETED)(P05772) [Completed]

Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846) [Completed]

Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817) [Completed]

Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771) [Completed]

6-Month Extension Trial of Asenapine With Olanzapine in Negative Symptom Patients Who Completed the Protocol 25543 (25544)(P05777) [Completed]

Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) [Completed]

Post-Authorization Safety Surveillance Study of Asenapine in Participants With Bipolar Disorder (P08307) [Active, not recruiting]

Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics [Completed]

Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis [Recruiting]

Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications [Enrolling by invitation]

MK-8189 Multiple Dose Study in Healthy Volunteers and Schizophrenia Patients (MK-8189-003) [Completed]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017